RU98119709A - Pharmaceuticals for the treatment of gastritis, reflux esophagitis, duodenitis, dyspepsia and ulcers - Google Patents

Pharmaceuticals for the treatment of gastritis, reflux esophagitis, duodenitis, dyspepsia and ulcers

Info

Publication number
RU98119709A
RU98119709A RU98119709/14A RU98119709A RU98119709A RU 98119709 A RU98119709 A RU 98119709A RU 98119709/14 A RU98119709/14 A RU 98119709/14A RU 98119709 A RU98119709 A RU 98119709A RU 98119709 A RU98119709 A RU 98119709A
Authority
RU
Russia
Prior art keywords
pharmaceutical preparation
duodenitis
dyspepsia
gastritis
ulcers
Prior art date
Application number
RU98119709/14A
Other languages
Russian (ru)
Other versions
RU2193407C2 (en
Inventor
Марсин Кроткиевски
Original Assignee
Марсин Кроткиевски
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9601219A external-priority patent/SE507682C2/en
Application filed by Марсин Кроткиевски filed Critical Марсин Кроткиевски
Publication of RU98119709A publication Critical patent/RU98119709A/en
Application granted granted Critical
Publication of RU2193407C2 publication Critical patent/RU2193407C2/en

Links

Claims (7)

1. Фармацевтический препарат для лечения гастритов, рефлюксэзофагитов, дуоденитов, диспепсии и язвы, отличающийся тем, что он содержат смесь цитрата и альгината висмута, и любой полученный реакционный продукт, особенно альгинат висмута.1. A pharmaceutical preparation for the treatment of gastritis, reflux esophagitis, duodenitis, dyspepsia and ulcers, characterized in that it contains a mixture of citrate and bismuth alginate, and any reaction product obtained, especially bismuth alginate. 2. Фармацевтический препарат или система по п.1, отличающиеся тем, что он дополнительно содержит одно или более антибиотическое вещество. 2. The pharmaceutical preparation or system according to claim 1, characterized in that it further comprises one or more antibiotic substances. 3. Фармацевтический препарат или система по п.2, отличающиеся тем, что упомянутые антибиотические вещества эффективны против Campyiobacter, особенно Heliobacter pyloris. 3. The pharmaceutical preparation or system according to claim 2, characterized in that said antibiotic substances are effective against Campyiobacter, especially Heliobacter pyloris. 4. Фармацевтический препарат или система по п.2, отличающиеся тем, что упомянутым антибиотическим веществом является амоксициллин. 4. The pharmaceutical preparation or system according to claim 2, characterized in that said antibiotic substance is amoxicillin. 5. Фармацевтический препарат или система по п.2, отличающиеся тем, что упомянутым антибиотическим веществом является метронизадол. 5. The pharmaceutical preparation or system according to claim 2, characterized in that said antibiotic substance is metronizadol. 6. Фармацевтический препарат по любому из предшествующих пунктов, отличающийся тем, что они дополнительно содержат агент, предпочтительно бикарбонат натрия, который будет вызывать нейтрализацию кислой среды желудка и вспенивание альгината висмута. 6. The pharmaceutical preparation according to any one of the preceding paragraphs, characterized in that they additionally contain an agent, preferably sodium bicarbonate, which will cause the neutralization of the acidic environment of the stomach and foaming of bismuth alginate. 7. Фармацевтический препарат или система по любому из предшествующих пунктов, отличающиеся тем, что они содержат медленно высвобождаемый агент. 7. The pharmaceutical preparation or system according to any one of the preceding paragraphs, characterized in that they contain a slowly released agent.
RU98119709/14A 1996-03-29 1997-03-27 Pharmaceutical preparations for treating gastritis, reflux esophagitis, duodenitis, dispepsia and ulcer RU2193407C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601219-0 1996-03-29
SE9601219A SE507682C2 (en) 1996-03-29 1996-03-29 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and peptic ulcer disease containing a mixture of ammonium bismuth citrate and an alginate

Publications (2)

Publication Number Publication Date
RU98119709A true RU98119709A (en) 2000-08-20
RU2193407C2 RU2193407C2 (en) 2002-11-27

Family

ID=20402012

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98119709/14A RU2193407C2 (en) 1996-03-29 1997-03-27 Pharmaceutical preparations for treating gastritis, reflux esophagitis, duodenitis, dispepsia and ulcer

Country Status (10)

Country Link
EP (1) EP0910388B1 (en)
JP (1) JP2000507572A (en)
AT (1) ATE224197T1 (en)
AU (1) AU2525397A (en)
DE (1) DE69715625T2 (en)
ES (1) ES2184081T3 (en)
PL (1) PL329152A1 (en)
RU (1) RU2193407C2 (en)
SE (1) SE507682C2 (en)
WO (1) WO1997036599A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0012487D0 (en) * 2000-05-24 2000-07-12 Pfylori Limited Use of metal compounds to treat gastrointestinal infections
WO2003043641A1 (en) * 2001-11-19 2003-05-30 Nobel Ilaç Sanayii Ve Ticaret A.S. New pharmaceutical combinations prepared with alginates and biphosphonates in order to prevent gastroesophageal reflux during use of oral biphoshonates
EP1761157A1 (en) * 2004-04-30 2007-03-14 ALTANA Pharma AG Method of classifying gerd
JP2006342085A (en) * 2005-06-08 2006-12-21 Kao Corp Gip secretion inhibitor
CN102558383B (en) * 2012-01-10 2014-07-23 中国科学院海洋研究所 Bismuth alginate and preparation method and application thereof
CN104524356A (en) * 2014-12-11 2015-04-22 吴燕 Traditional Chinese medicine composition for treating reflux esophagitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
EP0348143A3 (en) * 1988-06-21 1991-03-13 MARION LABORATORIES, INC. (a Delaware corporation) Bismuth derivatives of saccharide phosphates and sulphates
NL9220019A (en) * 1992-04-10 1994-04-05 Vnii Med Polimerov PHARMACEUTICAL COMPOSITION.
WO1995025521A1 (en) * 1994-03-24 1995-09-28 The Procter & Gamble Company Solid dose forms containing bismuth

Similar Documents

Publication Publication Date Title
IE801178L (en) 4-substituted-3-hydroxy-3-pyrroline-2,5-diones.
AU6076198A (en) Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
MA26435A1 (en) AMIDO-SUBSTITUTED BENZYLAMINE DERIVATIVES, THEIR PRECURSOR DERIVATIVES FOR MEDICAMENTS, THEIR PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND TREATMENT METHOD USING THE SAME.
NO990225D0 (en) Medications for the treatment of hyperphosphatemia
DE3884200D1 (en) Procedures for the treatment of mastitis and other staph infections.
DE69329448D1 (en) Pharmaceutical product
DE69527749D1 (en) Spherical activated carbon for the treatment of abdominal inflammation
PT1069892E (en) THERAPEUTIC SYSTEM ACTIVATED BY HUMIDITY
NO923643L (en) Drugs for the treatment of gastrointestinal disorders
MC1915A1 (en) Processes for the preparation of 2 ', 3'-dideoxynucleosides and pharmaceutical formulations containing them
RU98119709A (en) Pharmaceuticals for the treatment of gastritis, reflux esophagitis, duodenitis, dyspepsia and ulcers
DE68910175D1 (en) Adsorber module and adsorber apparatus for the treatment of whole blood.
IS1966B (en) Peptide p277 analogues and pharmaceutical compositions containing them, for the treatment or diagnosis of diabetes
WO1999009964A3 (en) Pharmaceutical composition containing clindamycin and clotrimazol for treating vaginal infections
DE69927584D1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF STOMACH DISEASES
NO982721L (en) Preserving solution
NO983465L (en) Combination pharmaceutical preparations containing LHRH analogues and antiestrogens for the treatment of gynecological disorders
DE69715625D1 (en) MEDICINAL PRODUCT FOR TREATING GASTRITIS, REFLUX-ÖSOPHAGITIS, DUODENITIS, DYSPEPSY AND ULCUS DISEASES
HUT49053A (en) Process for producing pharmaceutical composition comprising comt inhibitor as active ingredient and having action on gastrointestinal tract
RU97111095A (en) PREPARATION FOR PREVENTION AND TREATMENT OF ANIMAL ANIMAL HELMINTHES "ALBAMELIN"
DE69737088D1 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF FIV INFECTIONS
DK0688565T3 (en) Tablet, capsule or granules containing desogestrel
ATE71299T1 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF BACTERIAL INFECTIONS.
KR900017584A (en) Oral antitussive composition
ATE74767T1 (en) MEDICINAL COMPOSITION FOR THE TREATMENT OF LUNG OCCLUSION.